Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
9.71
-0.33 (-3.29%)
At close: Apr 28, 2026, 4:00 PM EDT
9.70
-0.01 (-0.10%)
After-hours: Apr 28, 2026, 7:03 PM EDT
Ardent Health Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Ardent Health stock have an average target of 13.2, with a low estimate of 10 and a high estimate of 17. The average target predicts an increase of 35.94% from the current stock price of 9.71.
Analyst Consensus: Buy
* Price targets were last updated on Mar 10, 2026.
Analyst Ratings
The average analyst rating for Ardent Health stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $14 → $13 | Buy | Maintains | $14 → $13 | +33.88% | Mar 10, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $16 → $15 | Buy | Maintains | $16 → $15 | +54.48% | Mar 6, 2026 |
| JP Morgan | JP Morgan | Hold Maintains $12 → $11 | Hold | Maintains | $12 → $11 | +13.29% | Jan 20, 2026 |
| UBS | UBS | Strong Buy Maintains $15 → $14 | Strong Buy | Maintains | $15 → $14 | +44.18% | Dec 18, 2025 |
| Mizuho | Mizuho | Buy Maintains $20 → $12 | Buy | Maintains | $20 → $12 | +23.58% | Dec 18, 2025 |
Financial Forecast
Revenue This Year
6.70B
from 6.32B
Increased by 5.91%
Revenue Next Year
7.01B
from 6.70B
Increased by 4.61%
EPS This Year
1.13
from 0.96
Increased by 17.72%
EPS Next Year
1.23
from 1.13
Increased by 9.28%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.0B | 7.4B | |
| Avg | 6.7B | 7.0B | |
| Low | 6.4B | 6.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.6% | 10.5% | |
| Avg | 5.9% | 4.6% | |
| Low | 1.1% | -2.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.26 | 1.53 | |
| Avg | 1.13 | 1.23 | |
| Low | 0.96 | 0.96 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 31.3% | 35.7% | |
| Avg | 17.7% | 9.3% | |
| Low | 0.0% | -15.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.